RE:RE:NEWSFunny, after getting rid of all the top scientist behind Prometic's science (Lyne Gagnon, Dr. Morin, and all the others who were fired), they buy another pharma start-up so they can get new scientist onboard.
BTW, Kenneth H. Galbraith is a Venture Partner at Genesys Capital Partners, Inc who owns the debenture of Fairhaven Pharmaceuticals Inc.